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• Items for this week’s EPI Update include: 
• Adverse health effects from ingestion of hand sanitizers 
•  Update on carbapenem-resistant Enterobacteriaceae (CRE) 
•  New meningococcal vaccine requirement for 2017-2018 school year 
•  Smallpox: a reminder 
•  Infographic: Healthy families and flocks 
• Meeting announcements and training opportunities 
Adverse health effects from ingestion of hand sanitizers 
Hand sanitizers can be a convenient alternative when soap and water are not available, 
but ingestion or improper use can be associated with health risks. The National Poison 
Data System found over 70,000 exposures to hand sanitizers reported in children 12 
years and under from 2011 to 2014. Over 90 percent of these exposures were among 
children 0-5 years old and were almost exclusively oral ingestions (97 percent). Children 
6-12 had more intentional exposure to alcohol-based sanitizers, suggesting possible 
deliberate alcohol abuse. 
  
Be aware of the potential danger associated with ingestion of alcohol hand sanitizers. 
Make sure alcohol hand sanitizers are used correctly, under adult supervision, and with 
proper child safety precautions and make sure they are stored out of reach of young 
children. Clinicians evaluating pediatric patients with clinical signs and symptoms 
consistent with alcohol toxicity, such as nausea, vomiting, respiratory depression, and 
drowsiness, or laboratory results consistent with ethanol or isopropanol toxicity, should 
consider the possibility of an alcohol hand sanitizer ingestion and contact their local 
poison control center. For more information, 
visit www.cdc.gov/mmwr/volumes/66/wr/mm6608a5.htm. 
  
Update on carbapenem-resistant Enterobacteriaceae (CRE) 
CREs are an emerging threat to public health and efforts are needed to prevent and 
contain the spread of these highly resistant organisms. Effective January 1, 2017, 
infections caused by CRE were added as a temporarily reportable disease in Iowa. 
IDPH defined CRE as follows: Enterobacteriaceae, including the following species: 
1) Klebsiella spp., 2) Enterobacter spp., 3) E. coli, or 4) Citrobacter spp., that: 
•         are resistant to any one of the following carbapenem antibiotics: imipenem, 
meropenem, doripenem, or ertapenem, based on current Clinical and Laboratory 
Standards Institutes Standards (M100) 
OR 
•         demonstrate production of a carbapenemase (enzymes that break down 
carbapenems and related antibiotics, and make them ineffective).  
 
Specimens should be submitted to the State Hygienic Laboratory for additional testing 
for the production of carbapenemase. 
 
Since surveillance began in Iowa, 30 cases of CRE have been reported. Of those, four 
have been identified as possessing a carbapenemase, including one with the OXA-48 
enzyme. Investigations are ongoing to determine additional risk factors and to 
implement infection prevention measures to stop the spread of CRE in Iowa. For more 
information on CRE, visitwww.cdc.gov/hai/organisms/cre/index.html. 
 
New meningococcal vaccine requirement for 2017-2018 school year 
Beginning in January of 2017, students enrolling in 7th and 12th grades are required to 
have the meningococcal (A, C, W, Y) vaccine. This will be fully implemented at the 
beginning of the 2017-2018 school year.  This change requires a one-time dose of 
meningococcal (A, C, W, Y) vaccine received on or after 10 years of age for applicants 
in grades 7 and above, if born after September 15, 2004; and 2 doses of meningococcal 
(A, C, W, Y) vaccines for applicants in grade 12, if born after September 15, 1999; or 1 
dose if received when applicants are 16 years of age or older. For more information, 
visit www.idph.iowa.gov/immtb/immunization/laws. 
 
Meningococcal disease caused by any serogroup is very serious. Approximately 10 to 
15 percent of people with meningococcal disease die even with appropriate treatment. 
Of those who recover, up to 20 percent suffer from serious after-effects, such as 
permanent hearing loss, limb loss, or brain damage. Meningococcal vaccines are very 
safe and effective at preventing meningococcal disease. The meningococcal vaccine is 
85 to 100 percent effective at preventing infection from the subtypes of meningococcus 
found in the vaccine. 
 
Smallpox: a reminder 
Smallpox was officially eradicated worldwide in 1980; however, reminders of this virus 
continue to pop up across the U.S. Just this week, IDPH received a call from a family 
member cleaning out an attic. The caller had found a vial, with a needle stuck in the top, 
labeled ‘smallpox vaccine.’ A similar situation happened in Iowa when an envelope was 
found labeled ‘smallpox scabs.’ So what does this mean for public health? 
  
Both items were carefully packaged and sterilized before being disposed of as medical 
waste, but these situations are a reminder to never forget a virus that made a large 
impact on history, as well as the global vaccination success story of its eradication. 
  
Before the age of the vaccine, smallpox killed three out of 10 infected individuals and 
left others permanently scarred. It was easily transmissible via body fluids and on 
inanimate objects. Today, there are only two locations where the virus can be found - at 
the CDC in Atlanta, Georgia, and at the State Research Center of Virology and 
Biotechnology in Koltsovo, Russia. 
  
The basis for vaccination began in 1796 with the cowpox virus, and in the 1800s 
switched to the vaccinia live attenuated vaccine. While smallpox vaccine is no longer 
used for the general public (due to its eradication), the U.S. has enough stockpiled that 
every U.S. citizen could be vaccinated should this disease ever appear again. 
  
Infographic: Healthy families and flocks 
 
  
Infographic available at www.cdc.gov/healthypets/resources/backyard-flock-8x11.pdf 
  
Meeting announcements and training opportunities 
None 
  
Have a healthy and happy (and windy, warm, then snowy) week! 
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